Many factors must come together to see a biotech venture succeed. Unique ideas and exceptional science discoveries are important criteria, as are risk-taking and entrepreneurial spirit. But no project can get off the ground without proper financing, suitable infrastructure or the correct people.
In the article “BaseLaunch – How to Launch and Build Exceptional Biotech Companies”, Virginia Ballotta, Manager New Ventures BaseLaunch and Yves Auberson, Executive Director in Global Discovery Chemistry Novartis Basel, observe how the Basel Area attracts brilliant minds in the field of biopharma. The authors describe BaseLaunch’s contribution to launching and developing new biotech projects and startups, turning them into success stories.
Read the full article below to learn more about BaseLaunch.